Changeflow GovPing Healthcare & Life Sciences MedImmune CAR Therapy Compositions and Methods ...
Routine Rule Added Final

MedImmune CAR Therapy Compositions and Methods for Treating Cancer, EP4138887A1

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

MedImmune, LLC has filed European patent application EP4138887A1 for compositions and methods of treating cancer using chimeric antigen receptors (CARs). The application was published by the European Patent Office on April 15, 2026, and lists five inventors: Gordon Moody, Maria Letizia Giardino Torchia, Michael Glen Overstreet, and Ryan Gilbreth. The filing is classified under A61K 39/00, C12N 5/0783, C12N 15/87, and A61P 35/00, and designates all EPC contracting states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 61 changes logged to date.

What changed

The European Patent Office has published MedImmune's patent application EP4138887A1, which covers compositions and methods for treating cancer using chimeric antigen receptors. This publication establishes a priority date and makes the application publicly available for opposition purposes. The filing includes MedImmune, LLC as the applicant and names four inventors.

Pharmaceutical and biotechnology companies developing CAR T-cell or related cancer immunotherapy products should review this publication for potential freedom-to-operate implications, assess whether their own development programs may overlap with the claimed subject matter, and consult patent counsel regarding any anticipated EPO prosecution timeline, examination requests, or potential opposition strategies once the application proceeds to grant.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS

Publication EP4138887A1 Kind: A1 Apr 15, 2026

Applicants

MedImmune, LLC

Inventors

MOODY, Gordon, GIARDINO TORCHIA, Maria, Letizia, OVERSTREET, Michael, Glen, GILBRETH, Ryan

IPC Classifications

A61K 39/00 20060101AFI20211029BHEP C12N 5/0783 20100101ALI20211029BHEP C12N 15/87 20060101ALI20211029BHEP A61P 35/00 20060101ALI20211029BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4138887A1

Who this affects

Applies to
Pharmaceutical companies Medical device makers Healthcare providers
Industry sector
3254.1 Biotechnology
Activity scope
Cancer treatment CAR T-cell therapy Patent filing
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!